Hedge Funds View Inspire Medical (INSP) as One of the Best Small-Cap Healthcare Stocks

Core Insights - Inspire Medical Systems Inc. (NYSE:INSP) is recognized as one of the top small-cap healthcare stocks favored by hedge funds [1] - Stifel has maintained a Buy rating on Inspire Medical Systems, noting that CMS confirmed new HGNS C-codes will be assigned to the same APC 5465 as CPT 64582, which keeps hospital facility fees largely unchanged [1] Reimbursement and Regulatory Updates - The confirmation from CMS removes a significant downside risk related to reimbursement, although uncertainties remain regarding physician fees and the potential impact of the -52 modifier, pending further regulatory guidance [2] - KeyBanc reported that CMS announced the addition of six new HCPCS codes effective January 1, 2026, which includes three codes for procedures related to Inspire Medical Systems [3] - The recent MLN Connects Newsletter highlighted ongoing confusion regarding hypoglossal nerve stimulation reimbursement, but the developments are viewed as directionally positive for clarifying long-term payment methods [4] Company Overview - Inspire Medical Systems is focused on developing and marketing treatments for obstructive sleep apnea (OSA), providing neurostimulation technology for the secure treatment of mild to severe OSA conditions [5]